Markets:

Overview

News

Currencies

International

Treasuries

Verastem, Inc. - Common Stock (NQ:VSTM)

6.125 -0.285 (-4.45%)

Streaming Delayed Price Updated: 1:54 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verastem, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone of Therapy for RAS Pathway-Driven Cancers

January 11, 2022

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 07, 2022

From Verastem Oncology

Via Business Wire

Verastem Oncology to Participate in Upcoming Investor Conferences

January 04, 2022

From Verastem Oncology

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review ↗

December 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novartis Receives FDA Nods For Arthritis Treatment And Cholesterol Drug...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (...

Via Benzinga

Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer

November 22, 2021

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at the Jefferies London Healthcare Conference

November 11, 2021

From Verastem Oncology

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 08, 2021

Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per...

Via Benzinga

Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress

November 04, 2021

From Verastem Oncology

Via Business Wire

Verastem Oncology Appoints Michelle Robertson to Board of Directors

October 26, 2021

From Verastem Oncology

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 20, 2021

Gainers Tenet Healthcare (NYSE:THC) stock r...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 27, 2021

Gainers Paratek Pharmaceuticals (NASDAQ:PRTK...

Via Benzinga

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 24, 2021

From Verastem Oncology

Via Business Wire

Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer

September 22, 2021

From Verastem Oncology

Via Business Wire

Why Verastem Stock Spiked Today ↗

September 20, 2021

A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today.

Via The Motley Fool

Why Verastem Shares Are Trading Higher Today ↗

September 20, 2021

Verastem Inc (NASDAQ: VSTM) is trading higher Monday after the company announced updated investigator-sponsored Phase 1/2 FRAME study data of VS-6766 with defactinib in low-...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

September 20, 2021

Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...

Via Benzinga

Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher ↗

September 20, 2021

Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 20, 2021

Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

September 20, 2021

Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing...

Via Benzinga

Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM (Sotorasib) in Patients with KRAS G12C-Mutant Non-Small Cell Lung Cancer

September 20, 2021

From Verastem Oncology

Via Business Wire

Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation ↗

September 20, 2021

Verastem Oncology Inc (NASDAQ: VSTM) stock is trading higher after updated data from the ongoing Phase 1/2 FRAME study. The investigator-sponsored study is...

Via Benzinga

Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021

September 19, 2021

From Verastem Oncology

Via Business Wire

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight ↗

September 19, 2021

Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical...

Via Benzinga

Verastem Oncology to Present at Upcoming Investor Conferences

September 07, 2021

From Verastem Oncology

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 03, 2021

Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3...

Via Benzinga

Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

August 02, 2021

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021

July 27, 2021

From Verastem Oncology

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.